Cargando…

Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma

Chronic hepatitis B virus (HBV) infected patients have an almost 100-fold increased risk to develop hepatocellular carcinoma (HCC). HCC is the fifth most common and third most deadly cancer worldwide. Up to 50% of newly diagnosed HCC cases are attributed to HBV infection. Early detection improves su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Hees, Stijn, Michielsen, Peter, Vanwolleghem, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055858/ https://www.ncbi.nlm.nih.gov/pubmed/27729734 http://dx.doi.org/10.3748/wjg.v22.i37.8271

Ejemplares similares

Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV
por: Vanwolleghem, Thomas, et al.
Publicado: (2021)

Biobanking for Viral Hepatitis Research
por: Ho, Erwin, et al.
Publicado: (2019)

Clinical management of chronic hepatitis B: A concise overview
por: Furquim d’Almeida, Arno, et al.
Publicado: (2021)

Viral hepatitis and hepatocellular carcinoma
por: Michielsen, Peter P, et al.
Publicado: (2005)

Point-of-Care Tests for Hepatitis B Are Associated with A Higher Linkage to Care and Lower Cost Compared to Venepuncture Sampling During Outreach Screenings in an Asian Migrant Population
por: Ho, Erwin, et al.
Publicado: (2020)

Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma
por: FU, YU, et al.
Publicado: (2013)

Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma
por: Yao, Mingjie, et al.
Publicado: (2016)

Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma
por: Zhu, Kai, et al.
Publicado: (2020)

Diagnostic and prognostic biomarkers of Human Leukocyte Antigen complex for hepatitis B virus-related hepatocellular carcinoma
por: Wang, Xiang-Kun, et al.
Publicado: (2019)

Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection
por: Ye, Fei, et al.
Publicado: (2021)

Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus–related hepatocellular carcinoma
por: Pratedrat, Pornpitra, et al.
Publicado: (2020)

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes
por: Van Hees, S., et al.
Publicado: (2018)

Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence
por: Liu, Yuanyuan, et al.
Publicado: (2021)

SOX4 as biomarker in hepatitis B virus-associated hepatocellular carcinoma
por: Huang, Jian-Lv, et al.
Publicado: (2021)

IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Yang, Jie-Ru, et al.
Publicado: (2022)

Diagnostic Value of Circulating microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Jin, Xuehang, et al.
Publicado: (2019)

The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis
por: Chang, Young, et al.
Publicado: (2022)

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma
por: Chen, Tingsong
Publicado: (2022)

Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma
por: Wang, Xiumei, et al.
Publicado: (2018)

Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
por: Song, Xiaoting, et al.
Publicado: (2020)

Diagnostic Performance of Circulating Tumor Cells for Predicting of Hepatocellular Carcinoma in Hepatitis C Virus-High Risk Patients: Role of Liquid Biopsy
por: El-Mezayen, Hatem A., et al.
Publicado: (2022)

Clinical and Diagnostic Significance of Homer1 in hepatitis B virus-induced Hepatocellular Carcinoma
por: Luo, Ping, et al.
Publicado: (2018)

Hepatitis B Virus and Primary Hepatocellular Carcinoma
por: Sutton, R. N. P.
Publicado: (1982)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Rizzo, Giacomo Emanuele Maria, et al.
Publicado: (2022)

Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma
por: Teng, Chiao-Fang, et al.
Publicado: (2020)

Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2019)

Screening and Identification of Potential Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis
por: Zeng, Xian-Chang, et al.
Publicado: (2020)

Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection
por: Deng, Huan, et al.
Publicado: (2020)

The potential of CircRNA1002 as a biomarker in hepatitis B virus-related hepatocellular carcinoma
por: Li, Ying, et al.
Publicado: (2022)

Hepatitis B Virus Genome Asymmetry in Hepatocellular Carcinoma
por: Shokrgozar, Zahra, et al.
Publicado: (2012)

Analysis of hepatocellular carcinoma associated with hepatitis B virus
por: Zheng, Litao
Publicado: (2023)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis
por: Huang, Yicheng, et al.
Publicado: (2022)

Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors
por: Huang, Rui, et al.
Publicado: (2022)

Mutations in hepatitis B virus small S genes predict postoperative survival in hepatocellular carcinoma
por: Peng, Li, et al.
Publicado: (2016)

Nucleotide variants in hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma
por: Chen, Xi, et al.
Publicado: (2021)

Development of Models to Predict Postoperative Complications for Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Bao, Mingyang, et al.
Publicado: (2021)

Identification of genes predicting unfavorable prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Sha, Meng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_79dkl5vmkvkcl35g4qqe6nvlbi